Ignite Creation Date:
2024-05-06 @ 3:41 AM
Last Modification Date:
2024-10-26 @ 11:37 AM
Study NCT ID:
NCT02343679
Status:
WITHDRAWN
Last Update Posted:
2017-02-01
First Post:
2014-12-03
Brief Title:
Novartis PhII Ceritinib LDK378 in RR ALK Hem Malignancies
Sponsor:
Anne Beaven MD
Organization:
Duke University
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-05
Start Date Type:
None
Primary Completion Date:
2020-10
Primary Completion Date Type:
ESTIMATED
Completion Date:
2022-10
Completion Date Type:
ESTIMATED
First Submit Date:
2014-12-03
First Submit QC Date:
January 16 2015
Study First Post Date:
2015-01-22
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-01-30
Last Update Post Date:
2017-02-01
Last Update Post Date Type:
ESTIMATED